Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with extensive-stage small cell lung cancer, confirmed through a laboratory test of tissue or cell samples
- People who are 18 years of age or older
- People for whom the treating doctor has determined that adebrelimab treatment is appropriate, or who are already receiving adebrelimab
Who may not be able to join:
- People who are currently taking other medicines or receiving therapies that affect the immune system
- People who are currently taking part in another clinical trial that involves a treatment or intervention
- People who have been diagnosed with another type of cancer at the same time
- People for whom important study-related information is incomplete or missing
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 (021)37798597
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Immune-related adverse events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.